Stock Option Grant and Employment of Matthew Katz

Fort Worth, TX (June 23, 2022) - PharmChem, Inc. (the "Company" or "PharmChem") (OTC: PCHM) today announces the grant of stock options to Matthew Katz, the Company's Chief Executive Officer, and the commencement of Mr. Katz's employment.

As previously announced, the Company's Board of Directors (the "Board") appointed Mr. Katz as the Company's Chief Executive Officer. Mr. Katz's first day of employment as PharmChem's CEO was June 23, 2022.

The Company today announces the grant of stock options to Mr. Katz in connection with his employment. The Board approved the grant of non-qualified stock options to Mr. Katz to purchase up to 265,000 shares of the Company's common stock (the "Options"), subject to various terms and conditions. The Options are exercisable at $4.60 per share.

About PharmChem, Inc.

PharmChem, Inc. (OTC: PCHM), headquartered in Fort Worth, TX, is the manufacturer and sole source provider of the PharmChek® Drugs of Abuse Sweat Patch.

0142949.0744357 4861-0560-1061v1

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

PharmChem Inc. published this content on 23 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 June 2022 20:25:08 UTC.